Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0032580
Disease: Adenomatous Polyposis Coli
Adenomatous Polyposis Coli
0.010 Biomarker disease BEFREE Therefore, we propose that KIF3B transports NR2A/APC complex and that its dysfunction is responsible for SCZ pathogenesis. 31746486 2020
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 GeneticVariation disease BEFREE To determine the effects of diabetes and Al exposure on the neural plasticity and inflammatory response in the hippocampus, we examined the levels of doublecortin (DCX), <i>N</i>-methyl-d-aspartate receptors (NMDAR1, NMDAR2A, and NMDAR2B), and ionized calcium-binding adapter molecule 1 (Iba-1) in the hippocampus. 30931101 2019
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.010 GeneticVariation group BEFREE To determine the effects of diabetes and Al exposure on the neural plasticity and inflammatory response in the hippocampus, we examined the levels of doublecortin (DCX), <i>N</i>-methyl-d-aspartate receptors (NMDAR1, NMDAR2A, and NMDAR2B), and ionized calcium-binding adapter molecule 1 (Iba-1) in the hippocampus. 30931101 2019
CUI: C0021125
Disease: Impulsive Behavior
Impulsive Behavior
0.010 AlteredExpression phenotype BEFREE We discovered that inherent motor impulsivity predicted responsiveness to D-cycloserine (DCS), a partial NMDAR agonist, which prompted the hypothesis that inherent motor impulsivity is associated with the pattern of expression of cortical NMDAR subunits (GluN1, GluN2A, GluN2B), specifically the protein levels and synaptosomal trafficking of the NMDAR subunits. 31295463 2019
CUI: C0022104
Disease: Irritable Bowel Syndrome
Irritable Bowel Syndrome
0.010 Biomarker disease BEFREE The IBS rat's abdomen is more sensitive and irritable; NR1, NR2A, and NR2B in ACC and NR1 and NR2B in colon of rats significantly increased in the model group versus the normal group (P<0.01) and were inhibited in all treatment groups (P<0.01, P<0.05). 30854008 2019
CUI: C0024131
Disease: Lupus Vulgaris
Lupus Vulgaris
0.010 AlteredExpression disease BEFREE To evaluate cognitive impairment related to memory deficits in a murine model of lupus induced by pristane in BALB/c mice related to mRNA relative expression levels of NR2A/2B hippocampal subunits in short and long-term memory task at 7 and 12 weeks after LPS exposition in a behavioral test with the use of Barnes maze. 31498792 2019
CUI: C0024138
Disease: Lupus Erythematosus, Discoid
Lupus Erythematosus, Discoid
0.010 AlteredExpression disease BEFREE To evaluate cognitive impairment related to memory deficits in a murine model of lupus induced by pristane in BALB/c mice related to mRNA relative expression levels of NR2A/2B hippocampal subunits in short and long-term memory task at 7 and 12 weeks after LPS exposition in a behavioral test with the use of Barnes maze. 31498792 2019
CUI: C0027765
Disease: nervous system disorder
nervous system disorder
0.010 AlteredExpression group BEFREE The GluN2A subunit is the most abundant expression of NMDA receptors in mature brain, and its dysfunction has been implicated in various neurological disorders. 31037756 2019
CUI: C0031117
Disease: Peripheral Neuropathy
Peripheral Neuropathy
0.010 Biomarker group BEFREE Several lines of evidence also support that peripheral nerve damage or inflammation may shift glutamatergic neurochemical transmission from N-methyl-D aspartate (NMDA) NR1/NR2A receptor- to NR1/NR2B receptor-mediated events (subunit switch). 31302238 2019
CUI: C0085281
Disease: Addictive Behavior
Addictive Behavior
0.010 AlteredExpression phenotype BEFREE Data obtained using Western blotting technique showed a significant increase in the level of GluN1 and GluN2B, but not in GluN2A subunits in all the three regions (mPFC, lPFC, and OFC) of men whom suffered from addiction as compared to the appropriate controls. 29766293 2019
CUI: C0409974
Disease: Lupus Erythematosus
Lupus Erythematosus
0.010 AlteredExpression disease BEFREE To evaluate cognitive impairment related to memory deficits in a murine model of lupus induced by pristane in BALB/c mice related to mRNA relative expression levels of NR2A/2B hippocampal subunits in short and long-term memory task at 7 and 12 weeks after LPS exposition in a behavioral test with the use of Barnes maze. 31498792 2019
CUI: C0524528
Disease: Pervasive Development Disorder
Pervasive Development Disorder
0.010 Biomarker group BEFREE Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorder. 30481555 2019
CUI: C0543888
Disease: Epileptic encephalopathy
Epileptic encephalopathy
0.010 GeneticVariation disease BEFREE Two unrelated individuals with epileptic encephalopathy carry a de novo variant in the gene encoding the GluN2A NMDA receptor subunit: a N615K missense variant in the M2 pore helix (GRIN2A<sup>C1845A</sup> ). 30604514 2019
CUI: C0016667
Disease: Fragile X Syndrome
Fragile X Syndrome
0.010 Biomarker disease BEFREE These findings suggest that GluN2A is a promising target in FXS research that could help us better understand the disorder. 30132892 2018
CUI: C0025362
Disease: Mental Retardation
Mental Retardation
0.010 GeneticVariation disease BEFREE Mutations and polymorphisms in GRIN2A gene, coding for GluN2A, are linked to developmental brain disorders such as mental retardation, epilepsy, schizophrenia. 29024713 2018
CUI: C0026650
Disease: Movement Disorders
Movement Disorders
0.010 GeneticVariation group BEFREE De novo GRIN2A mutations can give rise to a neurodevelopmental and movement disorder without epilepsy. 29644724 2018
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE Electrophysiological and behavioral studies showed that SHP1 binding potentiated GluN2A currents and evoked GluN2A-dependent pain hypersensitivity. 29758384 2018
CUI: C0085648
Disease: Synovial Cyst
Synovial Cyst
0.010 AlteredExpression disease BEFREE Atypical Expression and Activation of GluN2A- and GluN2B-Containing NMDA Receptors at Ganglion Cells during Retinal Degeneration. 30312782 2018
CUI: C0424605
Disease: Developmental delay (disorder)
Developmental delay (disorder)
0.010 GeneticVariation phenotype BEFREE Mutations in the GRIN2A gene, which encodes the GluN2A (glutamate [NMDA] receptor subunit epsilon-1) subunit of the N-methyl-d-aspartate receptor, have been identified in patients with epilepsy-aphasia spectrum disorders, idiopathic focal epilepsies with centrotemporal spikes, and epileptic encephalopathies with severe developmental delay. 29644724 2018
CUI: C0438696
Disease: Suicidal
Suicidal
0.010 GeneticVariation disease BEFREE We aimed to investigate the association of NR2A gene polymorphism with suicidal ideation in SLE while accounting for the interaction between clinical and psychosocial factors. 29161964 2018
CUI: C0740391
Disease: Middle Cerebral Artery Occlusion
Middle Cerebral Artery Occlusion
0.010 Biomarker disease BEFREE NMDAR2A was decreased by MCAO (P=0.015) but increased by EA (P=0.033). 30257960 2018
CUI: C1112263
Disease: Atypical benign partial epilepsy
Atypical benign partial epilepsy
0.010 GeneticVariation disease BEFREE Heterozygous GRIN2A mutations were detected in four patients (G760S, D1385Y, C455Y and C231R) GRIN2A mutation was found in 11.1% (1 out of 9 cases) of LKS, and in 7.1% (3 out of 42 cases) of ABPE, but in none with ECSWS and BECTS. 29056244 2018
CUI: C1258666
Disease: Myxoid cyst
Myxoid cyst
0.010 AlteredExpression disease BEFREE Atypical Expression and Activation of GluN2A- and GluN2B-Containing NMDA Receptors at Ganglion Cells during Retinal Degeneration. 30312782 2018
Mental Retardation, X-Linked, Syndromic, Christianson Type
0.010 Biomarker disease BEFREE The two published case reports and our observation suggests that ESES could be a constitutive feature of Christianson syndrome, as it has already been shown for other Mendelian epileptic disorders, such as GRIN2A and CNKSR2-related developmental epileptic encephalopathies. 30126759 2018
CUI: C0007786
Disease: Brain Ischemia
Brain Ischemia
0.010 Biomarker disease BEFREE The operation of brain ischemia/reperfusion was induced by bilateral common carotid artery occlusion for 20min in C57BL/6 and σ1r knockout mice as the ischemic group.A σ1r agonist, PRE084 (1mg/kg, i.p.), and NR2A antagonist, PEAQX (10mg/kg, i.p.), were administered once daily throughout the experiment. 28431607 2017